CLVT (Clarivate) Change In Working Capital : $-13 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Clarivate Change In Working Capital?

Clarivate's change in working capital for the quarter that ended in Mar. 2025 was $55 Mil.

Clarivate's change in working capital for the fiscal year that ended in Dec. 2024 was $-25 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Clarivate Change In Working Capital Historical Data

The historical data trend for Clarivate's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarivate Change In Working Capital Chart

Clarivate Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Working Capital

Get a 7-Day Free Trial

107.10

68.00

-271.90

-60.40

-24.90

Clarivate Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Working Capital	Get a 7-Day Free Trial															42.10	-57.00	42.30	-52.30	54.50

Clarivate Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Clarivate Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Clarivate's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarivate Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

16A:Germany 16A:Germany

Address

70 St. Mary Axe, London, GBR, EC3A 8BE

Website

https://www.clarivate.com

Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Executives

Andrew Miles Snyder	director	111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Bomba Jane L Okun	director	4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Saurabh Saha	director	C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Wendell E. Pritchett	director	TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Michael J Angelakis	director	40 MORRIS AVENUE, BRYN MAWR PA 19010
Bar Veinstein	officer: President, A&G	70 ST. MARY AXE, LONDON X0 EC3 8BA
Melanie Margolin	officer: Chief Legal Officer	1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Henry Levy	officer: President, LS&H	70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson	officer: President, IP Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Jonathan Gear	director, officer: Chief Executive Officer-Elect	C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton	officer: Senior VP, Finance/CAO	4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri	officer: Chief Technology Officer	70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins	officer: Executive Vice President/CFO	50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed	officer: President, Science Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Heather Matzke-hamlin	officer: Acting Chief Acctg Officer	4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY